CNN Arabic
CNN Arabic
جاهز للتشغيل
جاهز للتشغيل
A one-time genetic modification using the CRISPR-Cas9 technology successfully reduced bad cholesterol levels by up to 50% for over a year, without causing serious side effects. This was achieved in patients suffering from severe high cholesterol who did not respond to traditional medications. The study was small, involving 15 patients, and focused on targeting the liver, the primary organ responsible for regulating cholesterol and triglyceride levels. Initial results suggest that gene therapy could be an effective long-term alternative to medications, especially for young patients and those who do not adhere to statin therapy. Larger trials are ongoing to confirm these findings before regulatory approval.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading